• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Medtronic prices nearly $5B in debt tender

Medtronic prices nearly $5B in debt tender

July 11, 2019 By Brad Perriello

Medtronic logo updatedMedtronic (NYSE:MDT) yesterday priced a pair of debt tender offers at nearly $5 billion, raising the cap on two sets of senior notes.

Last week the Fridley, Minn.-based medical device giant closed a senior notes offering worth €5.0 billion that it’s planning to use to cover the tender offers, after raising the top end of one tender to more than $4 billion. Another tender was for  for up to $1.18 billion. Medtronic said yesterday that investors tendered $8.59 billion worth of senior notes.

In response the company raised the cap on its 4.625% senior notes due 2045 from $100 million to $150 million and boosted the cap on its 4.375% senior notes due 2035 from $200 million to approximately $450 million.

Here’s the breakdown of the $4.64 billion in tender offers accepted by the company:

Principal Amount Outstanding Principal Amount Tendered Principal Amount Accepted
4.125% Senior Notes due 2021 $500,000,000 $250,201,000 $250,201,000
3.125% Senior Notes due 2022 $675,000,000 $391,431,000 $391,431,000
Subtotal $1,175,000,000 $641,632,000 $641,632,000

 

Security Principal Amount Outstanding Principal Amount Tendered Principal Amount Accepted
6.500% Senior Notes due 2039 $182,949,000 $25,314,000 $25,314,000
5.550% Senior Notes due 2040 $305,910,000 $81,799,000 $81,799,000
4.625% Senior Notes due 2045 $1,963,341,000 $794,828,000 $150,000,000
4.625% Senior Notes due 2044 $176,594,000 $49,477,000 $49,477,000
4.500% Senior Notes due 2042 $128,650,000 $24,123,000 $24,123,000
4.375% Senior Notes due 2035 $2,381,619,000 $1,583,222,000 $450,003,000
4.000% Senior Notes due 2043 $325,024,000 $19,954,000 $19,954,000
3.500% Senior Notes due 2025 $4,000,000,000 $2,346,622,000 $1,300,038,000
3.625% Senior Notes due 2024 $850,000,000 $417,517,000 $417,517,000
6.550% Senior Notes due 2037 $283,536,000 $30,319,000 $30,319,000
3.350% Senior Notes due 2027 $850,000,000 $482,164,000 $482,164,000
3.150% Senior Notes due 2022 $2,500,000,000 $1,591,791,000 $965,604,000
3.200% Senior Notes due 2022 $650,000,000 $345,957,000 $0
2.950% Senior Notes due 2023 $309,516,000 $159,421,000 $0
SUBTOTAL $14,907,139,000 $7,952,508,000  $3,996,312,000
TOTAL $16,082,139,000 $8,594,140,000 $4,637,944,000

Barclays Capital, BofA Merrill Lynch and Goldman Sachs are co-dealer managers on the tender offers, with Global Bondholder Services acting as information and tender agent, Medtronic said.

Filed Under: Featured, Funding Roundup, Wall Street Beat Tagged With: Medtronic

More recent news

  • Former Shockwave Medical CEO joins Solenic Medical’s board
  • Anaconda Biomed brings in $56 million
  • Precision Neuroscience raises $250M in Series D for its BCI
  • Fresenius discontinuing Chinese sales of 4008A hemodialysis system
  • Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy